VIVALDIS GRAPITAIL 100MG 6'S TABLETS
Product details
Novel drug for osteoarthritic pain
- FDA approved in 2016 for Dogs
- Belongs to Piprant class of drugs
- Non-cyclooxygenase (COX)- inhibiting NSAID Prostaglandin Receptor Antagonists (PRA)
Benefits of Grapitail:
- First-in-Class-Non-COX Inhibiting NSAID- Grapiprant is a prostaglandin receptor antagonist (PRA), a non-COX inhibiting NSAID that specifically blocks the EP4 receptor, the primary mediator of canine OA pain and inflammation
- Use for All Stages of OA- Grapiprant can be used for all stages of canine OA, from the earliest clinical signs, and can be used as long as needed
- Safe to use Daily- Grapiprant is safe to use daily to deliver effective canine OA pain management
- Targeted Pain Relief-Blocks the EP4 receptor, the primary mediator of canine OA pain and inflammation
- Lower side effects-Reduces impact GI, Kidney and liver homeostasis
Indications:
- Grapitail (Grapiprant tablets) is indicated for the control of pain and inflammation associated with osteoarthritis in dogs
